Filter Results:
(89)
Show Results For
- All HBS Web
(180)
- News (51)
- Research (89)
- Events (2)
- Multimedia (3)
- Faculty Publications (47)
Show Results For
- All HBS Web
(180)
- News (51)
- Research (89)
- Events (2)
- Multimedia (3)
- Faculty Publications (47)
Sort by
- Article
No Evidence for an Effect of Testosterone Administration on Delay Discounting in Male University Students
By: Georgia Rada Ortner, Matthias Wibral, Anke Becker, Thomas Dohmen, Dietrich Klingmüller, Armin Falk and Bernd Weber
Intertemporal choices between a smaller sooner and a larger delayed reward are one of the most important types of decisions humans face in their everyday life. The degree to which individuals discount delayed rewards correlates with impulsiveness. Steep delay... View Details
Keywords: Delay Discounting; Impulsiveness; Intertemporal Choice; Testosterone; Decision Making; Behavior; Personal Characteristics
Rada Ortner, Georgia, Matthias Wibral, Anke Becker, Thomas Dohmen, Dietrich Klingmüller, Armin Falk, and Bernd Weber. "No Evidence for an Effect of Testosterone Administration on Delay Discounting in Male University Students." Psychoneuroendocrinology 38, no. 9 (September 2013): 1814–1818.
- December 2018 (Revised May 2019)
- Case
Darling Ingredients International
By: David E. Bell and Natalie Kindred
Led by CEO Randall Stuewe, Texas-based Darling Ingredients International was a rendering firm with $3.7 billion in 2017 revenues. Since 2003, Darling had transformed from U.S. focused into a global player in the processing of biological waste from meat and foodservice... View Details
Keywords: Darling; Ingredients; Stuewe; Rendering; Animal Byproducts; Used Cooking Oil; UCO; Diamond Green Diesel; DGD; Valero; Renewable Diesel; Biofuel; Recycling; Carbon; LCFS; Blend; Blender; Strategy; Corporate Strategy; Renewable Energy; Food; Agribusiness; Expansion; Diversification; Growth Management; Technological Innovation; Policy; Government Legislation; Agriculture and Agribusiness Industry; Energy Industry; Food and Beverage Industry; United States; Louisiana; California; Texas
Bell, David E., and Natalie Kindred. "Darling Ingredients International." Harvard Business School Case 519-048, December 2018. (Revised May 2019.)
- July 2011 (Revised January 2013)
- Case
Digital Microscopy Is Making Me Crazy!
By: Willy Shih
For Carl Zeiss Microimaging, modular hardware and software enabled customers to tailor Zeiss's broad range of microscopy systems hardware and software to meet a wide range of needs from basic scientific research in the biological and medical sciences to clinical... View Details
Keywords: Information Infrastructure; Applications and Software; Corporate Strategy; Disruptive Innovation; Science-Based Business; Management Analysis, Tools, and Techniques; Business Conglomerates; Digital Platforms; Opportunities; Medical Devices and Supplies Industry; Computer Industry
Shih, Willy. "Digital Microscopy Is Making Me Crazy!" Harvard Business School Case 612-002, July 2011. (Revised January 2013.)
- 2011
- Book
Capitalism: Its Origins and Evolution as a System of Governance
By: Bruce R. Scott
Capitalism, as defined in this book, is an indirect, three-level system of governance for economic relationships (i.e., economic, administrative, and political). Whereas economic markets can coordinate supply and demand within an existing system thanks to the invisible... View Details
Keywords: Economic Systems; Price; Governance; Government and Politics; Books; Markets; Relationships; System
Scott, Bruce R. Capitalism: Its Origins and Evolution as a System of Governance. Springer, 2011.
- 10 Oct 2007
- First Look
First Look: First Look: October 10
Working PapersTesting Limits to Policy Reversal: Evidence from Indian Privatizations Authors:Siddhartha G. Dastidar, Raymond Fisman, and Tarun Khanna Abstract We examine the effect of regime change on privatization using the 2004 election surprise in India. The... View Details
Keywords: Martha Lagace
- 2018
- Chapter
The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century
By: Nicholas Bagley, Benjamin Berger, Amitabh Chandra, Craig Garthwaite and Ariel Dora Stern
On the 35th anniversary of the adoption of the Orphan Drug Act (ODA), we describe the enormous changes in the markets for therapies for rare diseases that have emerged over recent decades. The most prominent example is the fact that the profit-maximizing price of new... View Details
Keywords: Health Care and Treatment; Laws and Statutes; Research and Development; Investment; Markets; Monopoly
Bagley, Nicholas, Benjamin Berger, Amitabh Chandra, Craig Garthwaite, and Ariel Dora Stern. "The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century." Chap. 4 in Innovation Policy and the Economy, Volume 19, edited by Josh Lerner and Scott Stern, 97–137. University of Chicago Press, 2018.
- Article
Everybody Else Is Doing It: Exploring Social Transmission of Lying Behavior
By: Heather E. Mann, Ximena Garcia-Rada, Daniel Houser and Dan Ariely
Lying is a common occurrence in social interactions, but what predicts whether an individual will tell a lie? While previous studies have focused on personality factors, here we asked whether lying tendencies might be transmitted through social networks. Using an... View Details
Mann, Heather E., Ximena Garcia-Rada, Daniel Houser, and Dan Ariely. "Everybody Else Is Doing It: Exploring Social Transmission of Lying Behavior." PLoS ONE 9, no. 10 (October 2014).
- February 2024
- Article
Are Many Sex/Gender Differences Really Power Differences?
By: Adam D. Galinsky, Aurora Turek, Grusha Agarwal, Eric M. Anicich, Derek D. Rucker, Hannah Riley Bowles, Nira Liberman, Chloe Levin and Joe C Magee
This research addresses the long-standing debate about the determinants of sex/gender differences. Evolutionary theorists trace many sex/gender differences back to natural selection and sex-specific adaptations. Sociocultural and biosocial theorists, in contrast,... View Details
Galinsky, Adam D., Aurora Turek, Grusha Agarwal, Eric M. Anicich, Derek D. Rucker, Hannah Riley Bowles, Nira Liberman, Chloe Levin, and Joe C Magee. "Are Many Sex/Gender Differences Really Power Differences?" PNAS Nexus 3, no. 2 (February 2024).
- 05 Aug 2015
- Research & Ideas
How Hormones Foretell Whether People Will Cheat
across the river, the scorpion stings the frog. "Sorry about that," says the scorpion, as they both drown. "It's just my nature." It turns out that people, like the scorpion, may be biologically predisposed to behaving badly. In short,... View Details
Keywords: by Carmen Nobel
- 19 Apr 2010
- Research & Ideas
The History of Beauty
dedicated to environmental sustainability with a broad social vision. Q: How much does the industry influence our notions of beauty, and how much do accepted or popular notions of beauty influence product development? A: The human desire to attract reflects basic View Details
- 08 Mar 2004
- Research & Ideas
Creating Value in Your Business Ecosystem
delivery of a company's own offerings. Like an individual species in a biological ecosystem, each member of a business ecosystem ultimately shares the fate of the network as a whole, regardless of that member's apparent strength. From... View Details
Keywords: by Marco Iansiti & Roy Levien
- 09 Oct 2001
- Research & Ideas
Driven: How Human Nature Shapes Organizations
In Driven: How Human Nature Shapes Our Choices, the authors combine the latest thinking from the biological and social sciences to lay out a new theory on human nature. The idea: We are all influenced and guided by four drives: acquiring,... View Details
Keywords: by Paul Lawrence & Nitin Nohria
- 12 Jun 2018
- Research & Ideas
In a Landscape of 'Me Too' Drug Development, What Spurs Radical Innovation?
too difficult to compare in terms of structural uniqueness. However, the researchers also found that cash windfalls led to an increase in the number of biologics developed. “They put that cash to work, so it seems, by working on more... View Details
- 04 Nov 2002
- What Do You Think?
What’s Best for the Corporate Brain?
Summing Up Those offering insights into ways to make the corporate brain function more effectively suggest that the corporate brain may be as complex as its biological counterpart. Respondents alternatively focused on learning, constant... View Details
Keywords: by James Heskett
- 05 Jun 2009
- Research Event
Business Summit: Niall Ferguson and the Certainty of Uncertainty
based on the map that is used. Optimized global networks may be vulnerable to crises. Business and political leaders are often surprised by crises; they don't take a long enough view of history. Biological evolution is a metaphor for the... View Details
Keywords: Re: John A. Quelch
- 14 Jul 2015
- First Look
First Look: July 14, 2015
In press Journal of Experimental Psychology: General Hormones and Ethics: Understanding the Biological Basis of Unethical Conduct By: Lee, Jooa Julia, Francesca Gino, Ellie Shuo Jin, Leslie K. Rice, and Robert A. Josephs... View Details
Keywords: Sean Silverthorne
- 24 Mar 2020
- Research & Ideas
These Coronavirus Heroes Show Us How Crisis Leadership Works
for COVID-19 and is currently able to run 1,000 tests per day. David A. Ricks, CEO of Eli Lilly. Under Ricks’ guidance, Lilly has teamed with AbCellera Biologics to find antibodies to disarm COVID-19. Looking for the correct antibody... View Details
- 09 Aug 2016
- First Look
August 9, 2016
drugs that have been shown to be therapeutically equivalent to an already approved original biologic drug—have only been approved in the United States since 2015. Europe has had biosimilar entry since 2006. This paper considers how... View Details
Keywords: Sean Silverthorne
- 31 May 2011
- First Look
First Look: May 31
confident of the market potential for mobile payments, they recognized the challenges they faced in scaling their current business model. Purchase this case:http://cb.hbsp.harvard.edu/cb/product/811029-PDF-ENG Office of Technology Transfer—Shanghai Institutes for View Details
Keywords: Sean Silverthorne
- 11 Sep 2007
- First Look
First Look: September 11, 2007
developing proven molecules from strategic partners to leapfrog competition and create large molecule biologics in India. The company understood that its transition from an API to an innovation-led company focused on new View Details
Keywords: Martha Lagace